Serum Institute OF India Private Limited Vaccine Export Data — India (DGFT 2022–2026)

Name: Serum Institute OF India Private Limited Vaccine Export Records India — #1 Exporter, 3,225 Shipments, $161.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Vaccine

India Pharmaceutical Trade Intelligence

$1.0B325 Suppliers192 CountriesHS 30024200

ExportsIndia → PAKISTAN8.5%India → NIGERIA8.1%

ImportsFRANCE → India$176.5B GERMANY → India$138.0B

#1 Supplier: SERUM INSTITUTE

Serum Institute OF India Private Limited — Vaccine Exporter #1 | $161.3M Trade Value | TransData Nexus | TransData Nexus

Serum Institute OF India Private Limited — Vaccine Exporter Profile

Indian Pharmaceutical Exporter · #1 for Vaccine · $161.3M export value · DGFT Verified

Serum Institute OF India Private Limited is the #1 Indian exporter of Vaccine with $161.3M in export value and 3,225 verified shipments. Serum Institute OF India Private Limited holds a 15.5% market share in Vaccine exports across 164 countries. The company exports 2 pharmaceutical products worth $162.2M across 1 therapeutic categories.

Serum Institute OF India Private Limited — Vaccine Export Profile: Buyers & Destinations

Serum Institute OF India Private Limited Vaccine export treemap — buyers and destination countries | TransData Nexus

Where Does Serum Institute OF India Private Limited Export Vaccine?

Country	Value	Shipments	Share
TURKEY	$4.9M	136	7.3%
PHILIPPINES	$4.2M	146	6.2%
NIGERIA	$2.5M	62	3.7%
EGYPT	$2.1M	83	3.1%

Who Are the Top Buyers of Vaccine from Serum Institute OF India Private Limited?

Buyer	Country	Value	Orders
UNICEF SUPPLY DIVISION	CONGO	$4.2M	99
XXICEXXSUPXXY DXXISIXX	AFGHANISTAN	$1.9M	48
GENPHARM INC	PHILIPPINES	$1.6M	59
TO THE ORDER OF TMBTHANACHART BANK	THAILAND	$1.5M	83
NATIONAL PRIMARY HEALTH CARE	NIGERIA	$1.4M	30
SERUM INSTITUTE INC	GUATEMALA	$1.2M	57
SERUM LIFE SCIENCES LTD	IRELAND	$1.2M	27
BIRMEX - LABORATORIOS DE BIOLOGICOS	MEXICO	$1.1M	35
XXRUMXXIFEXXCIEXXES XXD	SUDAN	$1.1M	24
SERUM LIFE SCIENCES LIMITED	SUDAN	$1.1M	24

Serum Institute OF India Private Limited supplies Vaccine to 668 buyers globally. The largest buyer is UNICEF SUPPLY DIVISION (CONGO), followed by XXICEXXSUPXXY DXXISIXX (AFGHANISTAN) and GENPHARM INC (PHILIPPINES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Vaccine Formulations Does Serum Institute OF India Private Limited Export?

Product Description / Formulation	Value	Shipments
[SINGLE VACCINES FOR HEPATITIS] HEPATITI	$3.3M	149
MIXED VACCINE FOR MMR-VIRAL VACCINE-	$2.5M	68
VACCINE FOR HUMAN MEDICINE-	$2.4M	70
OTHER MIX VACCINE-LIQUID VACCINE-	$2.2M	61
[MIXED VACCINES FOR DIPHTHERIA AND TETAN	$2.0M	69
SINGLE VACCINES FOR TB-	$1.4M	49
VACCINE FOR HUMAN MEDICINE [SINGLE VACCI	$1.4M	50
(SINGLE VACCINES FOR HEPATITIS) HEPATITI	$1.4M	90
VACCINE FOR HUMAN MEDICINE (SINGLE VACCI	$1.3M	44
OTHER SINGLE VACCINE-VIRAL VACCINE-	$1.3M	30

Serum Institute OF India Private Limited exports 1016 distinct Vaccine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is [SINGLE VACCINES FOR HEPATITIS] HEPATITI with 149 shipments worth $3.3M. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Serum Institute OF India Private Limited Compare to Nearest Vaccine Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	SERUM INSTITUTE OF INDIA PRIVATE LIMITED ★	$161.3M	3,225	164	$50.0K
2	BIOLOGICAL E. LIMITED	$43.0M	859	104	$50.0K
3	BHARAT BIOTECH INTERNATIONAL LIMITED	$30.4M	609	77	$50.0K

Serum Institute OF India Private Limited ranks #1 among 325 Indian Vaccine exporters. Average shipment value of $50.0K compared to the market average of $964.0K. The closest competitors by value are BIOLOGICAL E. LIMITED and BHARAT BIOTECH INTERNATIONAL LIMITED.

Which Indian Ports Ship Vaccine Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	3,489	24.3%
SAHAR AIR	2,995	20.9%
Bombay Air	855	6.0%
HYDERABAD ACC (INHYD4)	839	5.8%
HYDERABAD AIR	805	5.6%
DELHI AIR CARGO ACC (INDEL4)	752	5.2%
DELHI AIR	581	4.0%
AHEMDABAD AIR ACC (INAMD4)	373	2.6%

Geopolitical & Trade Policy Impact on Serum Institute OF India Private Limited's Vaccine Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like SII. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing increased freight charges and extended transit times. These disruptions have significantly impacted pharmaceutical exports to the Middle East, with potential losses estimated between ₹2,500 crore to ₹5,000 crore in March 2026. (fortuneindia.com) Such logistical challenges are particularly concerning for time-sensitive products like vaccines, where cold-chain integrity is paramount.

Conversely, the US-China trade tensions have created opportunities for Indian pharmaceutical companies. The imposition of tariffs on Chinese goods has led US importers to seek alternative suppliers, benefiting Indian exporters. However, the recent US tariffs on imports from multiple countries, including India, have introduced new complexities. These tariffs, reaching up to 39%, could affect nearly 55% of India's exports to the US, posing a significant challenge for companies like SII that rely on the American market. (apnews.com)

In the European Union, regulatory changes such as the Falsified Medicines Directive (FMD) have imposed stringent serialization and traceability requirements. Compliance with these regulations necessitates substantial investment in infrastructure and quality control systems. For SII, ensuring adherence to these evolving standards is crucial to maintaining access to the lucrative EU market.

Serum Institute OF India Private Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the US FDA and WHO emphasizing Good Manufacturing Practices (GMP). India, hosting over 600 US FDA-approved manufacturing sites, faces ongoing challenges in maintaining compliance. In 2023, the US FDA conducted more than 200 inspections in India, underscoring the critical importance of quality assurance. (fact.net.in)

For SII, maintaining compliance with international quality standards is imperative. The company's proactive approach is evident in its collaboration with the Coalition for Epidemic Preparedness Innovations (CEPI) in January 2024, aimed at enhancing rapid vaccine production capabilities. (outlookbusiness.com) Such partnerships not only bolster SII's regulatory standing but also reinforce its commitment to global health security.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Vaccine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Serum Institute OF India Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 3,225 individual customs records matching Serum Institute OF India Private Limited exporting Vaccine, covering 1016 formulations to 185 countries via 668 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 192+ countries, 2,202+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Vaccine

Vaccine

Serum Institute OF India Private Limited — Vaccine Exporter Profile

Serum Institute OF India Private Limited — Vaccine Export Profile: Buyers & Destinations

Where Does Serum Institute OF India Private Limited Export Vaccine?

Who Are the Top Buyers of Vaccine from Serum Institute OF India Private Limited?

What Is India's Total Vaccine Export Value and How Much Does Serum Institute OF India Private Limited Contribute?

What Is the Average Shipment Value for Serum Institute OF India Private Limited's Vaccine Exports?

How Does Serum Institute OF India Private Limited Compare to Other Indian Vaccine Exporters?

What Vaccine Formulations Does Serum Institute OF India Private Limited Export?

Regulatory Requirements: Exporting Vaccine to Key Markets

Nigeria — NAFDAC

How Does Serum Institute OF India Private Limited Compare to Nearest Vaccine Exporters?

Which Indian Ports Ship Vaccine Exports?

What Other Other Products Does Serum Institute OF India Private Limited Export?

Vaccine — Export Intelligence Video

Geopolitical & Trade Policy Impact on Serum Institute OF India Private Limited's Vaccine Exports

Serum Institute OF India Private Limited — Regulatory Compliance & Quality Standards

About Serum Institute OF India Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Vaccine Export Data from Serum Institute OF India Private Limited

Vaccine Stats

Company Overview

Top Products by Serum Institute OF India Private Limited

Related Analysis

Need Detailed Export Data?

Data Source